Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cerilliant Introduces New DMAA Certified Solution Standard

Published: Monday, May 13, 2013
Last Updated: Monday, May 13, 2013
Bookmark and Share
New certified Snap-N-Shoot® solution at a concentration of 1.0 mg/mL in methanol.

Cerilliant has introduced a new certified Snap-N-Shoot® solution of methylhexanamine or DMAA at a concentration of 1.0 mg/mL in methanol.

Also known as 1,3-dimethylamylamine or Geranamine, DMAA was marketed as a dietary supplement for weight loss, performance enhancement during sports activities or exercise or muscle building.

DMAA has been linked to numerous deaths over the last few years. In 2012, the US Food and Drug Administration (FDA) began issuing warning letters to manufacturers and distributors of
dietary supplements containing DMAA for lack of safety evidence.

As of April, 2013, the FDA is halting the sale of DMAA-containing dietary supplements by declaring these products illegal and using its regulatory authority to enforce removal of these products from the marketplace.

“FDA regulations impart dietary supplement manufacturers with the responsibility of ensuring product identity, purity, strength, quality, composition and that the product is not adulterated. Certified Reference Materials play a critical role in quality control testing of dietary supplements to ensure compliance.” states Lara Sparks, Cerilliant’s Vice President of Quality Assurance.

Cerilliant Snap-N-Shoot® reference solutions are prepared and certified to the highest industry standards including ISO Guide 34 and ISO/IEC 17025.

Preparation of Cerilliant reference solutions begins with full characterization of neat materials, including determination of chromatographic purity, residual solvent, residual water, and inorganic content to determine proper weighing adjustments which is critical to accuracy of the analyte concentration and lot-to-lot consistency.

Rigorous testing, from concentration certification to accelerated and real-time studies, ensures solution accuracy and shelf life for long-term storage and short-term transport from Cerilliant to the end user as well as for normal lab use.

Cerilliant’s DMAA reference solution compliments their current offering of phytochemical and dietary supplement certified Snap-N-Shoot® solutions including those for ephedra amines; vitamins A, B, D, and E; artificial sweeteners such as Reb A; and botanical mixes for Ginkgo biloba, Ginseng, and Green Tea.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Uncovering Cancer’s ‘Invisibility Cloak’
Researchers discover cancer cell mechanism to become invisible to the body's immune system.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!